** Shares of calibration service provider Transcat TRNS.O down as much as 8.5% to $79.19
** Brokerage Oppenheimer downgrades stock to "perform" from "outperform", removes PT
** Company posted Q3 results below expectations and lowered FY25 organic service growth forecast after market close on Monday, sending shares down as much as 24.2% on Tuesday
** Brokerage cites weaker forecast, reduced growth and margin improvement expectations, and impaired management credibility behind downgrade
** Says investors lost confidence in the company's growth stability, even as the company expects to return to historical growth rates in FY26, as reduced forecast implies organic service revenue decline in present quarter
** Three of five brokerages rate the stock "buy", two "hold"; with a median PT of $106, according to data compiled by LSEG
** TRNS fell ~3% in 2024
(Reporting by Neil J Kanatt in Bengaluru)
((Neil.JKanatt@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。